Lutris Pharma Ltd.
- Country
- 🇮🇱Israel
- Ownership
- Holding
- Established
- 2015-12-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.lutris-pharma.com
Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
- Conditions
- EGFRI Induced Acneiform Lesions
- Interventions
- Drug: LUT014 Gel (Dose 2)Drug: PlaceboDrug: LUT014 Gel (Dose 1)
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Lutris Pharma Ltd.
- Target Recruit Count
- 117
- Registration Number
- NCT04759664
- Locations
- 🇺🇸
Innovative Clinical Research Institute, Glendale, California, United States
🇺🇸UCLA, Santa Monica, California, United States
🇺🇸Miami Dermatology & Laser Research, Miami, Florida, United States
LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients
- Conditions
- Radiation Dermatitis
- Interventions
- Drug: LUT014 GelDrug: Placebo for LUT014 Gel
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Lutris Pharma Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT04261387
- Locations
- 🇺🇸
Columbus Regional Research Institute, Llc, Columbus, Georgia, United States
🇺🇸Willis-Knighton Cancer Center, Shreveport, Louisiana, United States
A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions
- First Posted Date
- 2019-03-15
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- Lutris Pharma Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT03876106
- Locations
- 🇺🇸
UCLA Health Santa Monica - Cancer Care, Los Angeles, California, United States
🇺🇸Washington University School of Medicine-Dermatology, Saint Louis, Missouri, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States